News

Flagship Pioneering and its portfolio companies make news because of their transformative approaches to solving global challenges. If you have needs beyond these resources, please contact press@flagshippioneering.com.

company

year

domain

Flagship Pioneering Announces Appointment of Pablo J. Cagnoni, M.D., as Executive Partner

11.02.2022

Seres Therapeutics Announces FDA Acceptance of Biologics License Application for Investigational Microbiome Therapeutic SER-109 for Recurrent C. Difficile Infection for Priority Review

Seres Therapeutics 10.26.2022

David Epstein to Step Down from Consulting Position at Flagship Pioneering

10.17.2022

Loading